Subset of stem cells identified as source for all cells in blood and immune systems

November 1, 2017, Fred Hutchinson Cancer Research Center
Credit: CC0 Public Domain

Researchers at Fred Hutchinson Cancer Research Center have identified a specific subset of adult blood stem cells that is exclusively responsible for repopulating the entire blood and immune system after a transplant.

The discovery, to be published Nov. 1 in Science Translational Medicine, has the potential to revolutionize blood as well as the delivery and targeting of cell and gene therapies that use healthy versions of the self-renewing stem cells to replace ones that are diseased.

Previously it was believed that several subtypes of are involved at different points in enabling a new blood system to take hold, from initial engraftment to a sustained, maintained healthy system.

"These findings came as a surprise; we had thought that there were multiple types of blood stem cells that take on different roles in rebuilding a blood and immune system," said senior author Dr. Hans-Peter Kiem, Endowed Chair for Cell and Gene Therapy and director of the Stem Cell and Gene Therapy Program at Fred Hutch.

"This population does it all," he said.

While the study was done in nonhuman primates, it shows that the newly identified cell corresponds to a subtype of human blood cell, which behaved identically when tested in vitro. Previous studies in mice report identifying such a subtype of blood stem cell, but there was no matching human version of it.

Blood stem cells are the building blocks of healthy bodies. They grow and proliferate into all the cells —T cells, B cells, platelets and more—that constitute the blood and immune systems. Treating blood stem cells or creating healthier versions of them are a focus of the fields of gene therapy and gene editing.

But it's been unclear which types of blood stem cells are most effective at carrying on the therapies. Finding the best cell target would mean better chances of lower side effects for patients.

"The gold standard target cell population for stem cell are cells with the marker CD34," said lead author Dr. Stefan Radtke, a research associate in the Kiem Lab at Fred Hutch. "But we used two additional markers to further distinguish the population from the other blood stem cells."

Using three protein markers that differentiate the cells from other varieties of blood stem cells, the Fred Hutch team found that a subpopulation of about 5 percent of all the blood stem cells did all the work in both early recovery and sustained maintenance of the newly rebuilt system.

Tracking hundreds of thousands of cells in the blood, the Fred Hutch team found that the specific stem cell group—marked as CD34+CD45RA-CD90+—started rebuilding all different cells of the blood and immune system within 10 days of being infused in nonhuman primates undergoing transplant. A year later, the researchers found strong molecular traces of those cells, indicating that the cells were responsible for the ongoing maintenance of the newly transplanted system.

"Our ability to track individual blood cells that developed after transplant was critical to demonstrating that these really are stem cells," said co-author Dr. Jennifer Adair, assistant member at Fred Hutch and an assistant professor of medical oncology at the University of Washington School of Medicine.

The cells potentially could make it much easier to do gene therapies for hemoglobin disorders, AIDS and blood cancers, Kiem said. The discovery may also have important implications for transplantation since it may lower the risk of graft-versus-host disease, a potentially fatal condition that can occur after hematopoietic for genetic diseases and blood cancers.

Ultimately, the treatment would work by isolating the subset of stem cells from a human sample and then engineering them in the lab to fix genetic flaws or provide disease-fighting powers. Once infused back into the patient, the cells would grow, divide and differentiate into healthy versions of all the in the reconstituted system.

The research team confirmed its findings using and is now working to move its findings into the clinic with hopes to be ready to integrate them in ongoing clinical trials. The researchers are currently looking for commercial partners.

Kiem, Radtke and Adair are co-inventors on patents related to this research. Because scientists at Fred Hutch played a role in developing the discoveries in this study, Fred Hutch and certain of its scientists could benefit financially from this work in the future.

Explore further: Fred Hutch researchers engineer complex immunotherapy that may target relapsing leukemia

More information: S. Radtke el al., "A distinct hematopoietic stem cell population for rapid multilineage engraftment in nonhuman primates," Science Translational Medicine (2017). stm.sciencemag.org/lookup/doi/ … scitranslmed.aan1145

Related Stories

Fred Hutch researchers engineer complex immunotherapy that may target relapsing leukemia

October 25, 2017
Oct. 25, 2017 - Researchers at Fred Hutchinson Cancer Research Center and the University of Washington have developed a novel way to genetically engineer T cells that may be effective for treating and preventing leukemia ...

Blood vessel cells improve the conversion of pluripotent stem cells to blood lineages

February 9, 2015
Hematopoietic stem cells (HSCs) can differentiate into all of the different types of cells that comprise the blood and immune cell lineages. HSC transplantation is the only effective treatment for certain blood disorders; ...

Blood study insight could improve stem cell therapy success

May 12, 2017
Researchers have pinpointed a key enzyme that is vital for the production of fresh blood cells in the body. The enzyme is essential for the survival of specialised stem cells that give rise to new blood cells, the study found. ...

'Educating' patients' immune cells may help combat diabetes

July 7, 2017
New research reveals that a treatment called Stem Cell Educator therapy is safe and effective for treating type 1 and type 2 diabetes. The therapy cultures the patient's immune cells with cord blood stem cells and returns ...

How blood can be rejuvenated

February 23, 2017
Our blood stem cells generate around a thousand billion new blood cells every day. But the blood stem cells' capacity to produce blood changes as we age. This leads to older people being more susceptible to anaemia, lowered ...

Recommended for you

Fetal gene therapy prevents fatal neurodegenerative disease

July 16, 2018
A fatal neurodegenerative condition known as Gaucher disease can be prevented in mice following fetal gene therapy, finds a new study led by UCL, the KK Women's and Children's Hospital and National University Health System ...

New study finds that fat consumption is the only cause of weight gain

July 13, 2018
Scientists from the University of Aberdeen and the Chinese Academy of Sciences have undertaken the largest study of its kind looking at what components of diet—fat, carbohydrates or protein—caused mice to gain weight.

Basic research in fruit flies leads to potential drug for diseases afflicting millions

July 13, 2018
River blindness and elephantiasis are debilitating diseases caused by parasitic worms that infect as many as 150 million people worldwide. They are among the "neglected tropical diseases" for which better treatments are desperately ...

Light based cochlear implant restores hearing in gerbils

July 12, 2018
A team of researchers with members from a variety of institutions across Germany has developed a new type of cochlear implant—one based on light. In their paper published in the journal Science Translational Medicine, the ...

Researchers discover gene that controls bone-to-fat ratio in bone marrow

July 12, 2018
In an unexpected discovery, UCLA researchers have found that a gene previously known to control human metabolism also controls the equilibrium of bone and fat in bone marrow as well as how an adult stem cell expresses its ...

Intensive care patients' muscles unable to use fats for energy

July 12, 2018
The muscles of people in intensive care are less able to use fats for energy, contributing to extensive loss of muscle mass, finds a new study co-led by UCL, King's College London and Guy's and St Thomas' NHS Foundation Trust.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.